Vicarious Surgical Inc. (RBOT) Key Metrics
RBOT valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $128,364
- Enterprise value
- $3.8M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 0.1 10-yr median 2.0
- EV / EBITDA
- 24.7
- Dividend yield
- —
- Beta
- 2.16
RBOT key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsRBOT valuation Price multiples at each fiscal year-end price.
RBOT returns How much profit the business earns on the capital it uses.
RBOT per-share figures Results divided by the shares outstanding at year-end.
RBOT financial health Debt, liquidity and how easily interest is covered.
RBOT efficiency & capital use Working capital cycle and where the cash goes.
RBOT valuation history
RBOT returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
RBOT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
RBOT price vs earnings per share
RBOT key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $12.9M | $77.5M | $53.5M | $257.4M | $1.03B | $1.04B | — |
| Enterprise value | $10.9M | $42.1M | −$29.8M | $156.8M | $853.7M | $1.03B | — |
| P/E ratio | — | — | — | 49.9 | — | — | — |
| Price / book | 1.3 | 1.7 | 0.5 | 2.3 | 12.3 | 61.9 | — |
| EV / EBITDA | — | — | — | 24.2 | — | — | — |
| Earnings yield | −389.4% | −81.6% | −132.7% | 2.0% | −3.4% | −1.2% | — |
| Free cash flow yield | −350.8% | −64.7% | −119.5% | −25.9% | −3.4% | −1.2% | — |
| Shareholder yield (dividends + buybacks) | — | — | — | 0.0% | — | — | — |
| Share price at fiscal year-end | $2.17 | $13.16 | $11.00 | $60.60 | $318.60 | $304.80 | — |
| Per share | |||||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$8.45 | −$10.74 | −$14.60 | $1.21 | −$10.93 | −$3.76 | −$1.70 |
| Operating cash flow per share | −$7.59 | −$8.49 | −$12.80 | −$14.41 | −$10.34 | −$3.51 | −$1.59 |
| Free cash flow per share | −$7.61 | −$8.52 | −$13.14 | −$15.67 | −$10.74 | −$3.55 | −$1.64 |
| Cash per share | $1.65 | $8.34 | $20.17 | $27.36 | $53.88 | $4.92 | $2.83 |
| Book value per share | $1.66 | $7.93 | $20.13 | $26.15 | $25.80 | $4.92 | $2.86 |
| Tangible book value per share | $1.66 | $7.93 | $20.13 | $26.15 | $25.80 | $4.92 | $2.86 |
| Capex per share | $0.02 | $0.03 | $0.34 | $1.26 | $0.40 | $0.04 | $0.05 |
| Debt per share | $1.31 | $2.34 | $3.05 | $3.69 | $0.42 | $0.03 | $0.03 |
| Shares outstanding | 5.9M | 5.9M | 4.9M | 4.2M | 3.2M | 3.4M | 5.5M |
| Change in shares outstanding | +0.9% | +20.9% | +14.6% | +31.9% | −6.0% | −37.3% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | −177.5% | −87.4% | −68.0% | 5.3% | −70.5% | −79.3% | −59.6% |
| Return on invested capital (ROIC) | −418.9% | −404.3% | −506.8% | — | — | — | — |
| Return on assets (ROA) | −115.0% | −67.4% | −54.6% | 3.2% | −35.3% | −75.4% | −56.9% |
| Return on tangible assets | −256.3% | −93.4% | −59.3% | 3.7% | −19.4% | −72.4% | −56.9% |
| Income quality (OCF / net income) | — | — | — | −11.87 | — | — | — |
| Financial health | |||||||
| Total debt | $7.8M | $13.8M | $14.8M | $15.7M | $1.3M | $110,000 | $158,000 |
| Cash & short-term investments | $9.8M | $49.1M | $98.2M | $116.2M | $173.5M | $16.9M | $15.5M |
| Net debt | −$2.0M | −$35.3M | −$83.3M | −$100.5M | −$172.2M | −$16.8M | −$15.3M |
| Debt / equity | 0.79 | 0.30 | 0.15 | 0.14 | 0.02 | 0.01 | 0.01 |
| Debt / assets | 0.40 | 0.20 | 0.12 | 0.11 | 0.01 | 0.01 | 0.01 |
| Net debt / EBITDA | — | — | — | −15.54 | — | — | — |
| Current ratio | 2.97 | 6.74 | 13.87 | 14.35 | 28.56 | 21.04 | 25.30 |
| Quick ratio | 2.97 | 6.74 | 13.87 | 14.35 | 28.56 | 21.04 | 25.30 |
| Interest coverage | — | — | — | -400.4 | -429.5 | — | — |
| Working capital | $7.7M | $44.0M | $93.7M | $112.0M | $172.1M | $16.3M | $15.1M |
| Invested capital | $7.8M | $11.4M | $14.6M | $10.5M | −$89.1M | $96,000 | $310,000 |
| Tangible asset value | $9.8M | $46.7M | $98.0M | $111.0M | $83.1M | $16.9M | $15.6M |
| Net current asset value | $1.8M | $30.7M | $79.1M | $91.2M | $79.8M | $16.2M | $15.0M |
| Graham number | — | — | — | $26.73 | — | — | — |
| Graham net-net per share | $0.01 | $4.77 | $15.67 | $20.48 | $23.27 | $4.65 | $2.70 |
| Capital allocation | |||||||
| Share buybacks (net) | — | — | — | $0 | — | — | — |
| Capex / depreciation | 0.09 | 0.09 | 0.90 | 4.82 | 4.08 | 0.76 | 2.37 |
| Efficiency | |||||||
| Days payables outstanding | 263.8 | 210.0 | 294.2 | 303.9 | 1,081.7 | — | — |
| Payables turnover | 1.38 | 1.74 | 1.24 | 1.20 | 0.34 | — | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average payables | $1.0M | $1.2M | $1.5M | $1.6M | $936,500 | $288,000 | $203,000 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from RBOT's annual financial statements (latest annual report filed March 9, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
RBOT valuation and financial ratios
Vicarious Surgical earned a return on equity of −177.5% and a return on invested capital of −418.9% in fiscal 2025. It ended the year with $7.8 million of debt and $9.8 million in cash and short-term investments, a net cash position of $2.0 million. The share count rose 8.6% from 5.5M to 5.9M over 6 years.
See the RBOT income statement, the RBOT chart for price history, or the RBOT stock overview for the latest quote and news.
RBOT key metrics FAQ
What is Vicarious Surgical's return on equity?
Vicarious Surgical's return on equity (ROE) was −177.5% in fiscal 2025: net income of -$50.2 million on average shareholders' equity of $28.3 million.
What is Vicarious Surgical's ROIC?
Vicarious Surgical's return on invested capital was −418.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Vicarious Surgical have?
Vicarious Surgical had total debt of $7.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.79 and more cash than debt.
What is Vicarious Surgical's free cash flow yield?
Vicarious Surgical generated -$45.2 million of free cash flow in fiscal 2025, a free cash flow yield of −350.8% on its market value at year-end ($12.9 million).
What is Vicarious Surgical's current ratio?
Vicarious Surgical's current ratio was 2.97 at the end of fiscal 2025: current assets were 2.97 times current liabilities.